ABSTRACT
Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency display autoantibodies (auto-Abs) neutralizing type I IFNs, conferring a predisposition to life-threatening COVID-19 pneumonia. We report that patients with autosomal recessive NIK or RelB deficiency, or a specific type of autosomal dominant (AD) NF-κB2 deficiency also display neutralizing auto-Abs against type I IFNs. They are prone to severe viral disease, including life-threatening COVID-19 pneumonia, influenza pneumonia, and severe form of varicella. Among patients with AD NF-κB2 deficiency, these auto-Abs are found only in heterozygotes with variants that are both transcriptionally loss-of-function (p52 activity), due to impaired p100 processing into p52, and regulatory gain-of-function (IκBδ activity), due to accumulation of unprocessed p100, thus increasing the inhibitory IκBδ activity (p52LOF/IκBδGOF). Conversely, neutralizing auto-Abs against type I IFNs are not found in individuals heterozygous for NFKB2 variants causing either p100 and p52 haploinsufficiency (p52LOF/IκBδLOF), or p52 gain-of-function (p52GOF/IκBδLOF). Unlike patients with APS-1, patients with disorders of NIK, RelB, or NF-κB2 harbor very few other auto-Abs. Their thymuses are however abnormally structured, and their medullary thymic epithelial cells (mTECs) have defective AIRE expression. Human inborn errors of the alternative NF-κB pathway impair thymic AIRE expression in mTECs, thereby underlying the production of auto-Ab against type I IFNs and predisposition to viral diseases.